Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Cash & Current Investments (2024 - 2025)

Carlsmed (CARL) has disclosed Cash & Current Investments for 2 consecutive years, with $110.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Current Investments rose 174.14% year-over-year to $110.0 million, compared with a TTM value of $110.0 million through Dec 2025, up 174.14%, and an annual FY2025 reading of $110.0 million, up 174.14% over the prior year.
  • Cash & Current Investments was $110.0 million for Q4 2025 at Carlsmed, down from $115.5 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $115.5 million in Q3 2025 and bottomed at $33.6 million in Q2 2025.